Session: New Antimicrobials and ID Diagnostics in the Pipeline - Fungal
1614 - Sponsor: Matinas BioPharma; Compound: MAT2203 (oral amphotericin B) leveraging a proprietary lipid nanocrystal drug delivery platform: currently being developed for treatment of Cryptococcal Meningitis in a Phase 2 Program
Saturday, October 22, 2022
8:10 AM – 8:20 AM US ET
Location: 145 AB
All relevant financial disclosures have been mitigated.